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Genome‑wide chromatin
accessibility analyses provide
a map for enhancing optic nerve
regeneration
Wolfgang Pita‑Thomas1, Tassia Mangetti Gonçalves1, Ajeet Kumar1, Guoyan Zhao1,2* &
Valeria Cavalli1,3,4*
Retinal Ganglion Cells (RGCs) lose their ability to grow axons during development. Adult RGCs thus
fail to regenerate their axons after injury, leading to vision loss. To uncover mechanisms that promote
regeneration of RGC axons, we identified transcription factors (TF) and open chromatin regions
that are enriched in rat embryonic RGCs (high axon growth capacity) compared to postnatal RGCs
(low axon growth capacity). We found that developmental stage-specific gene expression changes
correlated with changes in promoter chromatin accessibility. Binding motifs for TFs such as CREB,
CTCF, JUN and YY1 were enriched in the regions of the chromatin that were more accessible in
embryonic RGCs. Proteomic analysis of purified rat RGC nuclei confirmed the expression of TFs with
potential role in axon growth such as CREB, CTCF, YY1, and JUND. The CREB/ATF binding motif was
widespread at the open chromatin region of known pro-regenerative TFs, supporting a role of CREB in
regulating axon regeneration. Consistently, overexpression of CREB fused to the VP64 transactivation
domain in mouse RGCs promoted axon regeneration after optic nerve injury. Our study provides a
map of the chromatin accessibility during RGC development and highlights that TF associated with
developmental axon growth can stimulate axon regeneration in mature RGC.
Retinal Ganglion Cells (RGCs) in the retina receive visual information from bipolar cells and transmit it to several regions in the brain via axons projecting into the optic nerve. RGCs originate from retinal precursor cells
and most of them are born between E11 and E
 201. Transcription factors (TFs) such as Pax6, Math5, Pou4f2,
form a hierarchical network that regulates RGC differentiation from retinal precursors in space and time. Once
differentiated, RGCs grow their axons towards the brain through the optic nerve. Early born RGCs (born before
E16) arrive at the superior colliculus before birth while late born RGCs (born after E16) arrive at the superior
colliculus at P4/P52. Right before eye-opening (P12), all RGCs have formed stable synapses with their brain
targets, providing a functional visual system. The maturation of the visual system correlates with a decrease in
the regenerative capacity of RGCs. Therefore, RGC injury in adult mammals is followed by axon regeneration
failure and a degeneration process that leads to cell death. As a result, diseases that cause optic nerve damage
such as traumatic optic neuropathy, glaucoma, or optic nerve ischemia result in an irreversible loss of vision.
Identifying molecular and cellular mechanisms that increase survival and regeneration of RGC may offer new
treatment strategies for patients with glaucoma or other types of optic neuropathies.
RGCs lose their capacity to grow axons after birth3,4. Axon growth capacity in rat RGCs peak at embryonic
day 21 (E21), and start declining after birth reaching their minimum growth potential at postnatal day 11 (P11),
right before eye-opening4 suggesting that the axon growth program is substituted by a synapse function program.
Isolation of RGCs by immunopanning5, laser microdissection6, and cell s orting7 has enabled the identification of
gene expression changes between these developmental stages and the differences in axon growth capacity between
RGC subtypes. Multiple TFs that promote axon growth, such as C
 REB6, SOX118 and KLF75 are downregulated
during RGCs development. Other TFs that inhibit axon growth such as KLF4 and KLF9 are upregulated during
development5. Overexpressing KLF7 and Sox11, or deleting KLF4 and KLF9 promotes axon regeneration after
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optic nerve i njury5,8–11. Activating the CREB pathway by injecting compounds that mimic cAMP promotes modest regeneration after optic nerve injury12,13. Overexpressing CREB fused to the VP16 transactivation domain
promotes some axon regeneration in sensory neurons after spinal cord injury14, but the effect of CREB expression
in RGCs has not been tested. It has been shown that chromatin accessibility of some TF binding sites, such as
KLF7 binding site, is limited in mature cortical neurons, and that the transactivation domain VP16 is needed
to boost KLF7 activity in promoting r egeneration9,15. Therefore, chromatin accessibility may represent another
epigenetic mechanism controlling the axon regeneration program. Proteins that modify chromatin accessibility, such as histone deacetylases and histone acetyltransferase have also been shown to play a role in sensory
neuron16–20 and RGC21–24 regeneration. The interplay of TFs and chromatin accessibility regulates the expression levels of downstream genes such as Gap43 and Tubb3 whose final location is at the growth c one25. Some
of these downstream genes may also regulate signaling pathways that control metabolism. Activating pathways
that control endosome recycling, cell growth, and ribosome biogenesis such as overexpressing protrudin-126 to
mobilize endosomes into axons or deleting key regulators such as PTEN, IL22 or SOCS3 to stimulate the mTOR
and STAT3 pathways27–29 promotes abundant axon regeneration. Therefore, the interactions of genes that control growth cone dynamics and cell metabolism increase the axon growth capacity of RGCs. Altogether, these
studies point to the complex network of regenerative associated genes, epigenetics, TFs and downstream genes
regulating the decline in axon growth capacity during RGC development.
Analysis of chromatin accessibility has previously resulted in the prediction of target genes of TFs, the hierarchy of TFs in a given network, and the discovery of TFs with novel roles in developmental b
 iology30. Understanding the hierarchical order of these TFs and unraveling the chromatin accessibility at different developmental
stages may allow the reprogramming of adult RGCs for axon growth. Here we performed a comprehensive characterization of the gene expression, chromatin accessibility and nuclear proteome during the critical developmental period of axon growth decline in rat RGCs (E21 vs P11) using RNA-seq, ATAC-seq (Assay for TransposaseAccessible Chromatin using sequencing) and liquid chromatography–mass spectrometry (LC–MS). We found
that gene expression changes correlate with chromatin accessibility changes at the promoter region. Proteomic
analysis identified the expression of TFs with potential role in axon growth such as CREB, CTCF, YY1, and JUND.
Interestingly, CREB binding sites were significantly enriched in the open chromatin regions specific to the E21
RGCs. Overexpressing CREB fused to a VP64 transactivation domain in RGCs induced axon regeneration after
optic nerve injury, mimicking the axon growth capacity of embryonic neurons. Our data provides a road map
of the chromatin accessibility during RGC development and highlights that manipulating TFs associated with
developmental stages with high growth potential can stimulate axon growth in adulthood.

Results

Genetic programs that control axon growth are downregulated during RGC development. To
determine the transcriptional changes that occur between embryonic 21 days (E21) and postnatal 11 days
(P11) RGCs, RNA was extracted from immunopanned RGCs and sequenced in four independent replicates.
We identified 3,646 genes differentially regulated (log2 fold change > 1 and Benjamini–Hochberg corrected p
value < 0.01) between E21 and P11 RGCs (Fig. 1A, Supplementary Fig. 1A, and Supplementary File 1). There
were 1,116 genes differentially upregulated and 2,530 genes downregulated at E21 (Supplementary Fig. 1B).
RNA expression analysis showed that RGC marker genes such as Pou4f1 and RBPMS were highly enriched compared to markers of microglia, astrocyte, Muller cells, photoreceptor, bipolar, and amacrine cells (Supplementary
Fig. 1C), as expected from previous publications reporting 99% purity of RGCs derived from this immunopanning technique4. We also observed that many of the marker genes for RGC subtypes identified by single cell
sequencing, such as Opn4 (intrinsically photosensitive RGCs, ipRGCs), Nefh (αRGCs) and Cartpt (ON–OFF
directional sensitive RGCs, ooDSGCs)7, were expressed at lower levels at E21 and were significantly upregulated
at P11 (Supplementary Fig. 1C ). This suggests that E21 RGCs are not fully differentiated and that RGCs lose
their capacity to grow axons during their differentiation into different subtypes. Interestingly, some RGC subtypes such as ipRGCs and, especially, αRGCs retain some axon growth capacity while others such as ooDSGCs
do not7,31.
Gene Ontology (GO) analysis revealed that Biological Processes (BP) related to axon guidance and axonogenesis are enriched at E21 (Fig. 1B, Supplementary File 2), including genes whose protein products are localized
in RGC growth cones such as CRMP1, STMN1, GAP43, and β-tubulins, aligning with an essential role in axon
growth and pathfinding in E21 RGCs (Fig. 1F). GO Molecular Function revealed enrichment at P11 of genes
related to voltage-gated channels, including the L-type calcium channel Cav 1.4 subunit (Cacna1f) (Fig. 1C,F,
Supplementary File 2) aligning with their role in synapse function and neuronal activity at P11. It is noteworthy
that prior studies have shown that voltage gated ion channels, specifically L-type calcium channels, suppress
axon regeneration in sensory neurons32. GO analysis for Molecular Function also showed an enrichment of genes
related to transcription factors at both E21 and P11 (Fig. 1C, Supplementary File 2). We observed E21 upregulation of TF genes with known role in optic nerve axon regeneration such as Sox11, Klf6, Myc, and Klf7, and also
other TFs such as Dlx2, Runx1, Foxd1, Zic3, and Isl1 with described role in axon growth development. Interestingly, αRGCs have higher levels of Myc in postnatal stages compared to other s ubtypes33, suggesting high Myc
expression levels in αRGCs may partially explain their higher axon growth capacity. We did not observe major
changes in genes related to epigenetic regulation, with few exceptions such as HDAC10, which is upregulated at
E21 and HDAC11, which is downregulated at E21. We also observed postnatal upregulation of the MEF2 family
of TFs, which are known to work together with class IIa HDACs such as HDAC534. Whereas HDAC5 promotes
optic nerve regeneration23, deleting MEF2 members promotes RGC survival but not axon regeneration after
optic nerve injury35. The Molecular Function GO analysis also showed enrichment of genes related to growth
factor binding. We observed some key growth factor receptors genes upregulated in E21 such as Insr, Igf1r and
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Figure 1.  RNA-seq analysis of E21 and P11 purified RGCs. (A) Differentially expressed genes (DEGs)
between E21 and P11. The cut off for DEGs displayed in the figure was log2 fold change > 1 and false discovery
rate (FDR) adjusted p values < 0.01, which includes a Benjamini–Hochberg correction. Red represents gene
expression above average expression level across all samples. Blue represents gene expression below average
expression level across all samples. A total of 3,646 genes were differentially expressed, 1116 upregulated
and 2530 downregulated in E21. (B–D) Gene ontology (GO) analysis of the DEGs. A subset of the most
significantly enriched GO terms in (B) biological processes (BP), (C) molecular functions (MF) and (D) cellular
component (CC) are represented. GO terms with a FDR corrected p value < 0.05 were considered as significant.
(E) KEGG pathways analysis of DEGs. A subset of the twelve most significantly enriched pathways are
represented. (F) Gene expression change between E21 and P11 of key individual genes from the most relevant
pathways to axon growth in (B–D).
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◂Figure 2.  Chromatin accessibility changes at the promoter region, defined as < 3 kb from the transcription

start site (TSS), correlate with gene expression changes. (A) The distribution of open chromatin regions (OCRs)
with respect to the closest gene TSS in the 4 RGC samples is represented. The number of genes plotted for each
sample was 11,310 (E21_1), 11,572 (E21_2), 11,449 (P11_1), and 11,542 (P11_2). Each colored line represents
the location and length of the OCR respect the closest TSS but the intensity (height) of the peak is not depicted.
All four RGC samples came from independent rat litters, two samples per developmental stage. (B) Venn
diagram representing OCRs that were detected in both E21 samples (116,417), in both P11 samples (131,806),
or in all four samples (85,390). (C) Pearson correlation coefficient (p < 0.01) between E21 gene RNA expression
and the chromatin accessibility value (sum of all OCRs’ normalized peak height values) at the promoter region
of genes in E21. (D) Pearson correlation coefficient (p < 0.01) between P11 gene RNA expression and chromatin
accessibility at the promoter region of genes in P11. (E) Pearson correlation coefficient (p < 0.01) between the
changes of RNA expression and the changes of chromatin accessibility at the gene promoter regions between
E21 and P11. (F) Visual representation of chromatin accessibility of E21 and P11 replicates near the TSS of
regenerative associated genes Smad1 (promoter of axon growth) and Klf9 (inhibitor of axon growth). DORs are
represented in blue accordingly to the developmental stage where this region is more accessible.

Ngfr, which may contribute to a higher activation of PI3K/mTOR pathway at this stage providing a higher axon
growth potential. Surprisingly, we did not observe a differential expression of genes related to lipid metabolism
such as protrudin-1 (Zfyve27) suggesting that these changes may happen later during development. Cellular
components (CC) enriched at E21 are predominantly related to ribosomes suggesting active cell growth at this
stage (Fig. 1D, Supplementary File 2). A decline in ribosome gene expression has been observed during neuronal
development and has been related to the loss of axon growth c apacity36. Multiple ribosome genes are downregulated in P11 including Rpl24 and Rpl26, which have been previously implicated in axon growth decline during
development37. Genes related to extracellular matrix were also enriched at P11 (Fig. 1D, Supplementary File 2)
suggesting that RGCs regulate their surrounding extracellular matrix during development. We observed that
P11 RGCs upregulate matrix metalloproteinase 9 (MMP9) which is known to regulate cell death in these cells38.
Whether the interplay between RGCs and surrounding cells during development affects axon growth capacity
is unknown. KEGG (Kyoto Encyclopedia of Genes and Genomes biological) pathway a nalysis39–41 corroborated
that pathways related to ribosome function and axon guidance are enriched in E21, whereas neurophysiological
pathways typical of synapse function are enriched in P11 (Fig. 1E, Supplementary File 2). This transcriptional
analysis reveals that, as expected, E21 RGCs are in an active axon growth stage, whereas P11 RGCs have established synapses and downregulated the axon growth program.

Changes in gene expression correlate with changes in chromatin accessibility at the promoter
regions during RGC development. To determine the changes in chromatin accessibility between

embryonic and postnatal RGCs, immunopurified rat E21 and P11 RGCs were processed for ATAC-seq (n = 2
independent rat litters per developmental stage). DNA libraries were sequenced generating 40.9 ± 3.6 million
reads. ATAC-seq Integrative Analysis Package (AIAP) was used for sequence quality assurance, mapping, open
chromatin region (OCRs) calling, and downstream differential open chromatin a nalysis42. We obtained a total
of 33.8 ± 2.5 million mapped reads and 28.5 ± 2.6 million non-redundant unique mapped reads. We identified 150 ± 17.3 thousand OCRs for each sample43 and they were enriched near transcription start sites (TSS)
(Fig. 2A). PCA analysis of the OCRs present in each of the four samples demonstrated that embryonic and postnatal replicates clustered separately (Supplementary Figure S2A). Pearson correlation coefficient (PCC) between
the per-genomic region read count vectors at 1 kb and 5 kb resolution for each pair of samples was used to assess
the global similarity between biological replicates. The two biological replicates from each developmental stage
were highly correlated at both 1 kb (R > 0.96, P < 2.2e−16, Supplementary Fig. 2B) and 5 kb resolutions (R > 0.97,
P < 2.2e−16; data not shown), highlighting the quality and reproducibility of the data. The distribution of all the
OCRs in genomic features (promoters, UTR, exon, intron, downstream, and intergenic) were similar among all
the samples (Supplementary Fig. 2C).
To ensure robust results in downstream analyses, we only used OCRs that were identified in both biological
replicates for each developmental stage. A total of 116,417 OCRs were shared by both E21 samples, and 131,806
OCRs shared by both P11 samples (Fig. 2B). These OCRs, at either E21 or P11, were used to determine whether
mRNA expression levels correlate with chromatin accessibility at promoter region (< 3 kb from TSS), genic region
(intron and exon), and distal region (> 3 kb but < 100 kb from TSS) at each developmental stage. The value for
chromatin accessibility for each gene was defined as the sum of the average normalized peak counts of all the
OCRs associated with a gene at each studied region. The chromatin accessibility of the promoter region moderately correlated with the RNA expression at each stage (Fig. 2C,D). Also, the changes in chromatin accessibility
at the promoter region between E21 and P11 moderately correlated with the changes in RNA expression between
E21 and P11 (Fig. 2E). In contrast, the chromatin accessibility at the genic and distal region correlated very weakly
to RNA expression (Supplementary Fig. 2D–I). OCR visualization of selected RAGs, which were differentially
expressed at the mRNA level between E21 and P11 (i.e. Smad1, Myc, Jun, Klf2, and Klf9), confirmed that the
promoter region is more accessible in the stage with higher mRNA expression (Fig. 2F and Supplementary Fig. 4).
Next, we used DESeq2 implemented in AIAP to determine chromatin regions whose accessibility were statistically different between E21 and P11 (termed differentially opened regions, DORs) (Supplementary Fig. 3A). Of
the 116,417 OCRs identified in both of the E21 samples, 15,402 were significantly more accessible at embryonic
stage (E21 DORs; Fig. 3A) compared to postnatal. Conversely, of the 131,806 OCRs identified in P11 samples,
22,444 were more accessible at postnatal (P11 DORs; Fig. 3A). Interestingly, E21 DORs were highly enriched
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Figure 3.  Differentially open regions (DORs) are preferentially located at the promoter region of E21 genes and correlate with RNA
gene expression changes. (A) The number of OCRs that were present in both samples of each developmental stage and the number of
DORs (cross-hatched area) obtained using D
 ESeq269 implemented in the ATAC-seq Integrative Analysis Package (AIAP) package with
default parameters. (B) Distribution of DORs with respect the closest gene TSS. (C) Read count frequency of DORs with respect to
TSS. (D) Distribution of DORs in the different regions of the genome. (E) Number of DORs at the promoter region (< 3 kb from TSS),
distal region (> 3 kb but < 100 kb from TSS), and genic (intron + exon) region. (F) Genes associated with DORs present at the promoter,
distal, and genic region. (G) RNA expression changes at E21 and P11 in relation to the presence of DORs at the promoter region. Each
row represents a gene that is associated with only E21 DORs (green), only P11 DORs (red), or both E21 and P11 DORs (purple). (H)
Pearson correlation coefficient (p < 0.01) of log2 fold changes in gene expression between E21 and P11 and log2 fold changes in peak
signal of DORs that are located in the promoter regions.

Scientific Reports |
Vol:.(1234567890)

(2021) 11:14924 |

https://doi.org/10.1038/s41598-021-94341-y

6

www.nature.com/scientificreports/
at TSS compared to P11 DORs (Fig. 3B,C). More E21 DORs were located within promoters whereas P11 DORs
were more prominent in introns compared to E21 (Fig. 3 D). As a result, we identified 1,583 E21 DORs and 747
P11 DORs in the promoter region (< 3 kb from TSS) (Fig. 3E). Genes associated with these DORs were identified, resulting in 1,427 genes associated with E21 DORs (Fig. 3F) including RAGs such as Smad1, Tubb3, Jun,
and Myc (Fig. 2F and Supplementary Fig. 4). We found 689 genes that were associated with P11 DORs (Fig. 3F)
including RAGs such as Klf9 and Klf2 (Fig. 2F and Supplementary Fig. 4). Only 29 genes were associated with
both E21 and P11 DORs in the promoter region, with chromatin openness changing in opposite directions
during development (Fig. 3F). Interestingly, The E21 DOR- associated genes had fewer OCRs at P11 and those
OCRs were evenly dispersed across the 3 kb regions surrounding the TSS (Supplementary Fig. 3B). The P11
DOR-associated genes had also fewer OCRs at E21. However, those OCRs were enriched in the TSS regions
(Supplementary Fig. 2E). These results demonstrate that the E21 and P11 DOR associated-genes have distinct
chromatin accessibility between these two developmental stages.
Next we investigated the relationship between changes of chromatin openness at the DORs and changes in
mRNA expression of the DOR-associated genes between E21 and P11. The stage-specific increase of RNA expression levels of the DOR-associated gene is associated with the presence of stage-specific DORs at the promoter
region (Fig. 3G) but not DORs at the genic or distal regions (Supplementary Fig. 3C,E). The changes in mRNA
expression of the DOR-associated genes and the changes in chromatin accessibility of the DORs have a moderate
but significant correlation at the promoter region (Fig. 3G,H). In contrast, we observed a very weak correlation
at the genic region and no significant correlation at the distal region (Supplementary Fig. 3C–F).

TF binding sites (TFBSs) are enriched in developmental stage‑specific DORs. To identify potential TFs regulating the transcriptional change between E21 and P11, we performed TF binding motif enrichment
analysis to identify TFBSs that were enriched in the DORs of either E21 or P11, located in the promoters, since
these regions significantly correlated with mRNA expression (Fig. 3G). Overrepresentation index (ORI), which
takes into account the frequency and the density of a particular binding motif in a set of target sequences44,
was calculated to measure how much more probable it is to find a particular TF binding motif in stage specific
DORs than in a random background set in the genome. We identified six binding motifs that were exclusively
enriched (false discovery rate (FDR) adjusted p values < 0.01) at E21 DORs but not at P11 DORs (Fig. 4A and
Supplementary File 3). The TFs associated with these binding motifs include CREB/ATF, E74A (mammalian
ortholog: ELF), bZIP911, v-Jun, ACAAT, and CCAAT. However, these last 4 binding motifs appear in less than
5% of the DORs undermining a widespread role regulating the E21 transcriptome. In contrast CREB/ATF and
E74A appeared in more than 50% of the DORs supporting an important role in regulating E21 genes (Supplementary File 3). We also found 78 binding motifs that were exclusively enriched in P11 DORs but not in E21
(Supplementary File 3) including MEF2, BACH, and RAR-related orphan receptors (Fig. 4B). Binding motifs of
certain TFs were found to be enriched in both E21 and P11 DORs suggesting that they control different genes
depending on the cellular context. Some of these binding motifs were more predominant in one particular stage
as shown by the ORI ratio (Log2 E21 ORI/P11 ORI; Supplementary Fig. 5 and Supplementary File 3). These TFs
include TAX/CREB, NRF-1, E2F, MYC, HIF1, and c-JUN in E21, and LXR in P11. Some of them has been shown
to have a role in axon growth such as M
 YC45, HIF146, c-Jun47 and NRF-148. This suggests that their activity or the
number of genes they regulate may vary during development.
We additionally performed TFBS enrichment analysis using HOMER s oftware49 (Supplementary File 4). In
this case, the percentage of DORs containing the TF motif is calculated for E21 and P11 DORs and compared
to a random background sequence obtained from the complementary regions of the OCRs to calculate statistical differences. Therefore, TF binding motifs that appeared significantly more in DORs than in a background
sequence were considered to be enriched in the promoter region (Supplementary File 4). Twenty-three and seven
TF motifs for E21 and P11, respectively, were significantly enriched (Benjamini adjusted p values < 0.01) for at
least two folds in the DORs compared to the background set (Fig. 4C,D and Supplementary File 4) and appeared
in more than 5% of DORs at the specific developmental stage. Interestingly, these TF binding motifs are uniquely
enriched in one of the developmental stages which supports their role in controlling programs at a specific developmental stage. We found binding motifs being enriched exclusively in E21 DORs such as CREB, c-MYC, CTCF,
YY1, RFX, JUND, NRF1, ELF1, and E2F (Fig. 4C) and other set of binding motifs being enriched exclusively in
P11 DORs, such as MEF-2, BACH2, and ROR receptors (Fig. 4D). Other TFs that have been described as proregenerative in the literature such as S OX48, HIF146 and S TAT350 were also significantly enriched in E21 DORs
with frequencies 1.6 to 1.9 times higher than the background set (Supplementary File 4), although is lower than
the stringent cutoff we set in Fig. 4C. Interestingly, CREB and MEF2 motifs were found to be uniquely enriched
in E21 and P11 respectively, by both methods which utilize different TFBS motif database and very different
statistical frameworks. Many TFBS motifs found to be more highly enriched in E21 than P11 by ORI ratio were
found to be uniquely enriched in E21 by HOMER, e.g. MYC, JUND, NRF1 and E2F, demonstrating consistent
high activity of those TFs in E21. The mRNA expression levels of most TFs correlated with their binding motif
enrichment at their given developmental stage (Fig. 4E) supporting the role of TFs, such as CREB, c-MYC,
JUND, NRF1, CTCF, E2F7, RFX, YY1 and MEF2 in regulating RGC transcriptional change during development.
Proteomic analysis of RGC nuclear fractions confirms the presence of TFs regulating transcrip‑
tional change. Since the presence of an mRNA does not always guarantee the presence of its corresponding

protein, we performed a proteomic analysis of isolated nuclei from E21 and P11 RGCs to identify TFs that are
expressed in RGC nuclei at the protein level. A total of six E21 samples and five P11 samples were analyzed by
LC–MS (Supplementary File 5). We identified 1192 proteins present in RGC nuclei. GO enrichment analysis
showed that these proteins were enriched for nuclear function-related terms (Fig. 4F), confirming that nuclei
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◂Figure 4.  TF Binding site motifs enriched at DORs located in the promoter regions. (A) Overrepresentation

index (ORI) of TF binding motifs that are exclusively enriched at E21 DORs located in the promoter regions
(FDR adjusted p values < 0.01). Deep green indicates binding motifs that appear in greater than 5% of DORs.
(B) ORI of TF binding motifs that are exclusively enriched at P11 DORs located in the promoter regions. (C)
TF binding motifs that are exclusively enriched at E21 DORs located in the promoter regions according to the
HOMER analysis. (D) TF binding motifs that are exclusively enriched at P11 DORs located in the promoter
regions according to the HOMER analysis. Only binding motifs that are present in more than 5% of all the
DORs in either E21 or P11 and are at least two fold more enriched than the background set are plotted (FDR
adjusted p values < 0.01). (E) TFs with binding motifs in (C,D) that appeared in RNA-seq data were plotted over
light green (E21) and light red (P11) background respectively. X-axis: HOMER frequency ratio from (C,D),
y-axis: log2 fold change of the transcription factor RNA expression levels between the two stages. HOMER
frequency ratio in P11 was represented with a negative value. (F) Cellular component GO analysis of proteins
identified in RGC nuclei by proteomics. (G) Protein peak intensity of selected TFs (from A and B analysis) in
E21 and P11 RGC nuclei isolated from rat independent litters (n = 4 for each developmental stage). Protein peak
intensity is normalized to total amount of protein of each sample. The black line represents the average of these
samples in either E21 or P11 for each TF. Transcription factors in blue in (A–E) are those that were detected by
proteomic analysis (LC–MS) in RGC nuclei. For ORI of TF binding motifs, the p-value was calculated according
to the method described in75. Motif enrichment was calculated with cumulative binomial distributions statistics
in HOMER49.

isolation was efficient, in line with what was previously reported23. Uniprot analysis indicated that 72 of the
proteins identified have DNA-binding activity and were detected in at least one sample (Supplementary File 5).
These proteins included several of the TFs that have enriched binding motifs in DORs such as CREB, JUND,
c-MYC, CTCF, YY1, ATF2, MEF2a, and MEF2d (Fig. 4A–D). We next quantified the expression levels of these
TFs by normalizing the peak intensity for each TF in LC–MS to the total protein levels in the sample (Fig. 4G).

CREB binding domain motifs are widespread at the promoter region of E21 DEGs. Since we
detected the presence of CREB and ATF2 at the protein level in RGC nuclei (Fig. 4G) and the CREB/ATF binding motif is enriched at E21 DORs in our binding motif analysis (Fig. 5A), we focused on this binding motif to
identify the specific pathways regulated by CREB in E21 RGCs. From the 766 DEGs that have at least one OCR
in their promoter, CREB/ATF binding motif appeared in 498 of them. We performed Biological Processes GO
analysis for the group of genes with CREB/ATF binding motifs and found that these genes predominantly regulate neuron differentiation, axonogenesis and cytoplasmic translation (Fig. 5B). We next performed Molecular
Function GO analysis and found that CREB/ATF binding motif predominantly appears in the promoter of genes
that have DNA binding transcription factor activity including regenerative TFs such as SMAD1, KLF7, MYC, or
SOX11, and also ribosome genes (Fig. 5C). GO Cellular Component analysis confirmed that many of the genes
with CREB/ATF binding motif at their promoter region are ribosomal (Fig. 5D). Altogether, these analyses suggest that CREB occupies a high rank in the hierarchical order of regenerative TFs and also plays an important
role regulating ribosome biogenesis.
CREB‑VP64 overexpression promotes optic nerve regeneration. Our ORI and HOMER analysis

revealed that CREB binding motifs are enriched in E21 DORs, suggesting that during development, CREB target gene regulation decreases as axon growth capacity declines. Therefore, we tested if overexpressing an active
form of CREB would promote axon regeneration. To achieve this, we fused CREB to the VP64 transactivation
domain, a tetramer of the 11 amino acids minimal activation domain of VP16, which significantly increases
the recruitment of transcriptional machinery and increases activation compared to VP1651. Previous studies
have demonstrated that the addition of VP16 on pro-regenerative transcription factors increases their ability to
drive regeneration in vivo9,14,52. We performed intravitreal injections of AAV-CREB-VP64 fusion, or AAV-GFP
as a control, as described previously23. This procedure achieves expression of the transgene in ~ 70% of RBPMS
positive RGCs (Supplemental Fig. 6). Fourteen days after viral injection, we performed optic nerve crush injury.
After another fourteen days, retina were dissected to quantify cell survival or the fluorescently labeled cholera
toxin b was injected to trace regenerating axons. We found that overexpression of CREB-VP64 did not significantly increase RGC survival two weeks post optic nerve injury compared to GFP control (Fig. 6A,B). However,
overexpression of CREB-VP64 significantly promoted optic nerve regeneration compared to GFP control, tripling the number of regenerating axons (Fig. 6C,D). The extent of axon regeneration we observed two weeks
after optic nerve injury is similar to what has been reported by manipulating SOX11, c-Myc or S OCS38,27,45 or
by expressing the combination of the transcription factors Oct4-Sox2-Klf411. These results indicate that CREBVP64 promote RGC axon regeneration, supporting a key role for the CREB-dependent transcription program
in the axon growth capacity of RGCs. Further studies will be needed to test if CREB overexpression synergizes
with other TFs like ATF2 or other strategies targeting the mTOR signaling pathways23,29,31,53 or DNA methylation patterns11.

Discussion

In the present study, we used RNA-seq, ATAC-seq, and proteomics analyses to identify the key TFs regulating
RGC axon growth capacity during development. We have shown that the RNA expression of genes that control
axon growth and ribosome biogenesis are downregulated during RGC development, and that the mRNA expression changes correlate with chromatin accessibility changes at the promoter region. We found that binding motifs
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Figure 5.  CREB/ATF motif identified at the promoter of genes that are changing during development. (A)
Sequence motif logo of the CREB/ATF position weight matrix. (B-D) Gene hubs obtained by gene ontology
analysis of E21 upregulated genes containing CREB/ATF binding motif at their promoter OCRs (For pathways
analysis, FDR corrected p value < 0.05 were considered as significant.). (B) Eight most significantly enriched
biological processes are represented. (C) Five most significantly enriched molecular functions are represented
(D) Eight most significantly enriched cellular components are represented.

of several TFs that are present at the protein level such as CREB, JUND, CTCF and YY1 are enriched at these
chromatin regions. The CREB/ATF motif is especially prevalent, and is enriched at the promoter regions of other
regenerative TFs, suggesting a high rank of CREB in the hierarchical order of TFs regulating axon growth. In
accordance with this role, overexpressing CREB fused to the VP64 transactivation domain in RGCs promotes
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Figure 6.  Overexpressing CREB-VP64 promotes optic nerve regeneration. (A) Representative images of retinal
wholemounts stained for RBPMS (white) to label RGCs in the uninjured and injured condition 2 weeks after
optic nerve crush. Scale bars = 50 µm. (B) Quantification of RGC survival 2 weeks post crush. Eyes injected
with AAV2-CREB-VP64 (n = 7 animals) showed a trend towards increased survival compared to eyes injected
with AAV2-GFP that was not significant (unpaired T-test. p = 0.1308). Error bars represent mean ± SEM. (C)
Representative images of optic nerves sections showing regenerative fibers of mice intravitreally injected with
either AAV2-CREB-VP64 or AAV2-GFP. Scale bar = 250 µm. (D) Number of regenerative fibers at various
distances. Multiple t-test analysis with Holm-Sodak correction. * p adj < 0.05. n = 6 optic nerves per treatment.
Four optic nerve sections were used to calculate the average for each nerve. Box-Whiskers plot was used
where the box represents the 25th and 75th percentiles, the inside line represents the median, and the whiskers
represents the largest and smallest values.
optic nerve regeneration to a similar extent as targeting the mTOR pathway23,29,31,53, DNA methylation11 or
expressing the transcription factors Sox11, c-Myc or SOCS38,27,45 or protrudin26, partially reverting the poor
regenerative capacity of adult RGCs.
Our analysis provides a map of the chromatin accessibility in acutely purified retinal ganglion cells at two
different stages of development. Immunopanning enabled us to obtain a sufficient number of cells with purity
close to 99% and with good RNA and DNA integrity. A downside is that it takes a few hours to dissociate and
isolate the RGCs, which may result in gene expression changes. However, previous studies have shown that
those changes are s mall54 and limited to immediate early g enes7 and thus do not preclude obtaining reliable
gene expression data. Since RGCs represent less than 0.5% of all the cells in the retina, our study provides more
specific information of the TFs regulating axon growth than studies analyzing whole retina t issue30,55. Specifically, we found that the downregulation of genes in postnatal stages, such as axon growth genes and ribosomal
genes, correlates with specific promoter regions becoming less accessible. In contrast, genes that regulate synapse
function are upregulated during development and their promoter regions become more accessible. Our results
are consistent with the observation that in the cortex, there is a developmental change in promoter accessibility
that correlates with gene e xpression56. Venkatesh et al. study demonstrates that the target genes of the key RAGs
STAT3 and JUN, but not SOX11 and KLF6, become less accessible in the adult s tage56. This study was however
limited by using a heterogenous population of cortical cells, whose proportions are dynamically changing during development. Another advantage of our study is that we complemented our TF binding motif analysis with
proteomic analysis of RGC nuclei. This allowed us to confirm the presence at the protein level of several of
the TFs whose binding motifs were enriched at DORs such as CREB, JUND, CTCF, YY1, and ATF2. We also
observed TFs whose target regions are becoming less accessible during RGC development including TFs with
known roles in axon regeneration, such as CREB, JUN, SOX4, c-MYC, CTCF and HIF15,8,14,20,45–47, as well as
other TFs whose roles in axon regeneration have not been thoroughly studied such as YY1, NRF1 and RFX.
Interestingly, KLF’s motifs were not found to be predominantly enriched at any stage. KLF6 and KLF7 are highly
expressed in embryonic stage, whereas KLF2 and KLF9 are highly expressed in postnatal s tage5, and these TFs
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have opposing effects in axon growth. Since TFs of the same family bind to similar motifs, it is possible that we
were not able to distinguish whether the binding motif present at the DOR is from an axon growth promoting
(KLF6 and KLF7) or axon growth inhibitory KLF (KLF9 and KLF2). We also found that the promoter regions
of regenerative RAGs such as SMAD1, MYC and TUBB3 were less accessible in P11 RGCs compared to E21. In
Zebrafish, a species that can successfully regenerate axons in the optic nerve, chromatin accessibility does not
significantly change between non injured RGCs and regenerating R
 GCs55. This suggests that in zebrafish, the
chromatin remains fairly open at the target genes of regenerative TFs, whereas in mammals, the chromatin closes
during development, limiting the access of regenerative TFs to activate the expression of RAGs after optic nerve
injury. Altogether, these results supports the notion that in mammals, axon growth decline might be explained
by the limited accessibility of TFs to certain regions of the chromatin.
Our chromatin analysis also showed that the DORs at the promoter of postnatal genes are enriched for certain
TF binding motifs, including MEF2. Interestingly, MEF2 isoforms were upregulated in postnatal stage in our
RNA-seq data, and MEF2A and MEF2D were also identified at the protein level in postnatal RGC nuclei. This
suggests that MEF2 might have an important role in regulating RGC maturation and potentially axon growth
inhibition. However, it has been recently shown that deleting MEF2 or overexpressing a MEF2 dominant negative isoform promote RGC survival but not optic nerve regeneration35.
It is noteworthy that the expression levels of CREB do not change between E21 and P11 according to our
RNA-seq and proteomics data. This contrasts with prior studies showing that CREB is higher in actively growing
RGCs compared to those that have already reached their targets6. Our approach does not allow us to differentiate between those two developmental states, which may explain why the higher expression at E21 in our data is
unable to reach statistical significance. Another possibility is that differences in axon growth capacity between
the two stages may be not entirely relate to a higher expression of CREB but also to a higher activation state
of CREB in RGCs. Our chromatin accessibility analysis allowed us to identify CREB motifs in DORs suggesting that this TF is regulating transcriptional changes in embryonic stage. CREB activity is regulated by cAMP
levels and previous studies have shown that the levels of cAMP drop after birth during CNS and PNS neuron
development57. In rat RGC, cAMP levels are three times higher in E18 compared to P557. This suggests that CREB
is activated and regulating axon growth genes in embryonic RGCs. After birth, cAMP levels drop and therefore
transcription of axon growth genes by CREB ceases. Interestingly, activating CREB by increasing cAMP levels
in vivo has shown controversial results. Some studies reported modest increase in optic nerve r egeneration58,
whereas others showed that increasing cAMP alone was not sufficient to promote optic nerve regeneration,
but could when combined with other stimuli such as providing neurotrophic f actors59, oncomodulin or PTEN
deletion13. In addition, elevating cAMP in cultured RGCs by adding forskolin does not fully revert the axon
growth decline observed in postnatal RGC4. We observed that the chromatin in the promoter region of axon
growth promoting genes is less accessible in postnatal RGCs, suggesting that endogenous CREB activated by
cAMP may be unable to effectively access these chromatin sites to promote regeneration in adult RGCs15. We
demonstrate that expression of CREB fused to the transactivation domain VP64 in adult RGCs promotes optic
nerve regeneration. Therefore, CREB-VP64, but not endogenous CREB activated by cAMP, might be able to
open the chromatin of pro-regenerative CREB target genes to induce optic nerve regeneration. Transactivation
domains such as VP16 and VP64 are well-known chromatin-modifying agents that open chromatin and greatly
activate transcription60. However, it is possible that other TFs in combination with CREB-VP64 could further
increase the number of regenerating RGC and the distance at which they regenerate. Combining CREB-VP64
with other TFs or treatments targeting the neurotrophic factor CNTF61,62, mTOR23,29,31,53 or DNA methylation11
might provide a synergistic effect in optic nerve regeneration.

Methods

Retinal Ganglion cell immunopanning purification. All animal protocols were approved by the
Washington University School of Medicine Institutional Animal Care and Use Committee (IACUC) under protocol A3381-01. All experiments were performed in accordance with the relevant guidelines and regulations. All
experimental protocols involving rats and mice were approved by Washington University School of Medicine
(protocol #20180128). Mice and rats were housed and cared for in the Washington University School of Medicine
animal care facility. This facility is accredited by the Association for Assessment & Accreditation of Laboratory
Animal Care (AALAC) and conforms to the PHS guidelines for Animal Care. Accreditation—7/18/97, USDA
Accreditation: Registration # 43-R-008. The study was carried out in compliance with the ARRIVE guidelines63.
The isolation of RGCs was performed by using a slightly modified version of the immunopanning procedure
originally established in Barres laboratory64. For embryonic RGCs, E21 day pregnant Sprague Dawley rats were
euthanized by CO2 and embryos were transferred to a plate with DPBS where retinas were dissected out and
cleaned. For postnatal RGCs, P11 Sprague Dawley pups were euthanized by C
 O2 and eyes were transferred to
DPBS medium where retinas were dissected. Next, RGCs were isolated as previously described23. Briefly, retinas
were transferred to a filtered solution of papain in DPBS containing 2 mg of L-Cysteine and 2000 units of DNAse.
For E21 retina, 140 units of papain were added. For P11, 200 units were added. After 30 min, enzymatic solution
was removed and retinas were triturated to obtain a single cell solution. RGCs were isolated by immunopanning. First by negative selection using an anti-macrophage antibody and then positive selection using anti-thy1
antibody. RGCs attached to the plate were trypsinized, counted in a Neubauer, and centrifuged for subsequent
processing. The procedure of dissociating and panning cells, which lasts 3–4 h, may result in gene expression
changes. However, previous studies have shown that gene expression changes during tissue dissociation are
small54 and limited to immediate early genes7. Therefore this technique is suitable for comparing the transcriptome of the purified cells in two different developmental stages.
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RNA sequencing and analysis. Total RNA from 700,000 to 1.25 million RGCs from four independent
rat litters per developmental stage was isolated using the Qiagen RNAeasy kit from Qiagen, which included a
15 min On-column DNAse step. RNA was stored at − 80 °C and sent to Genome Technology Access Center at
Washington University for library preparation and sequencing. RNA quality was assessed using an Agilent Bioanalyzer (RIN > 9.5). Samples were subjected to DNase treatment. rRNA depletion was achieved with the RiboZero rRNA removal kit. Library preparation was performed using the SMARTer kit (Clontech), and sequencing
performed on an Illumina HiSeq3000. Basecalls and demultiplexing were performed with Illumina’s bcl2fastq
software and a custom python demultiplexing program with a maximum of one mismatch in the indexing
read. Sequences were adapter-trimmed using Cutadapt 1.1665 and subjected to quality control using PRINSEQ
0.20.466 and aligned to Rat (Rattus norvegicus) annotations based on genome assembly RNOR6 using STAR
2.5.3a67. Reads in features were counted using HTseq 0.6.168. Genes differentially expressed between conditions
were identified using DESeq269 with log2FC > 1.0 and a false discovery rate (FDR) adjusted p values < 0.01, which
includes a Benjamini–Hochberg correction69. Variance stabilizing transformation (VST) normalized counts
were calculated using DESeq2, and normalized gene counts were converted to Z scores for plotting. Heatmaps
were generated using ComplexHeatmap R package70. Sequencing performance was assessed for total number
of aligned reads, total number of uniquely aligned reads, genes and transcripts detected, ribosomal fraction,
known junction saturation, and reads distribution over known gene models with RSeQC 2.6.2471. R package
clusterProfiler72 was used for GO and KEGG pathway enrichment analysis and plotting. GO and KEGG pathway
terms with FDR corrected p value < 0.05 were considered as significant. R version 4.0.4 was used for statistical
analysis and plotting.
R (citation: R Core Team (2013). R: A language and environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. http://www.R-project.org/).
ATAC‑Seq and data analysis. After isolation, 300,000 RGCs from two independent rat litters per devel-

opmental stage were centrifuged and resuspended in Neurobasal/B27 + medium and 10% DMSO, to quick frozen at − 80 °C. Samples were processed by UCSD Center of Epigenomic Technologies using their proprietary
assay for Transposase-Accessible Chromatin coupled with high-throughput sequencing (ATAC-seq). ATAC-seq
Integrative Analysis Package (AIAP) was used for sequence quality assurance, mapping, open chromatin region
(OCR) calling42. We used D
 ESeq269 implemented in the ATAC-seq Integrative Analysis Package for downstream
differential open chromatin region identification. Those OCRs that have FDR adjusted p value < 0.01 and log
twofold change > 1 were considered DORs (differentially open regions). Following data quality control analyses
were performed for each sample and across the projects: (1) Reads under peak percentage ranged 31.6–39.3%.
(2) Signal enrichments around the TSS relative to genome wide average, a metric which identifies datasets with
high signal to noise ratios, ranged 10.8–14.4%. (3) Pearson correlation coefficient between the two replicates
were calculated to measure the concordance between the two biological replicates. To ensure the robustness of
our analysis we used only OCRs that were present in both biological replicates of either stage for downstream
analyses. This ensures that only the most robust peaks were included in the analyses.

Transcription factor binding motif enrichment analysis and CREB target analysis. To identify

candidate transcription factors that regulate differentially expressed genes, the HOMER49 and motif over-representation index (Motif-ORI)44 algorithms were used to identify transcription factor binding sites enriched in the
differentially open region. Genomic regions complementary to the region of all the called OCRs (considered as
all of the non-open regions in the genome) were obtained and were provided as the background set sequence for
HOMER analysis. This non-open region set was used as input to perform random sampling of genomic regions
to obtain a set of genomic regions with the same number and length distribution as a set of query sequences.
This random sampled genomic region sequences were provided as the background set sequence for Motif-ORI
analysis and this analysis is repeated 100 times and statistical significance was calculated using a Student’s t-test
with the NULL hypothesis that ORI is not significantly larger than 1.2, a stringent cutoff determined in previous publication44 to distinguish enriched motifs. A motif with Benjamini–Hochberg procedure corrected p
value < 0.05 were considered as significant. The TF logo image was generated using e noLOGOS73.
To identify targets of CREB, sequence of OCR peaks were retrieved using BEDTools74 and was scanned using
Patser to identify CREB binding sites. The Patser program calculates the probability of observing a sequence
with a particular score or greater75,76 for the given matrix and determines the default cutoff score based on that
p-value. Any gene with at least one CREB binding site in one of the gene-associated OCR peaks was counted
as target gene.

RGC nuclei proteome characterization by LC–MS. Nuclei from 700,000–1.25 million RGCs from 6
E21 and 5 P11 independent rat litters were isolated using the Thermo Scientific NE-PER Nuclear and Cytoplasmic Extraction Kit. Next, trypsin digestion was perform by adding a buffer containing 100 mM ammonium
bicarbonate, 10 mM TCEP and 25 mM iodoacetamide followed by digestion with trypsin at 37 °C overnight.
The digested sample was acidified with 1%TFA then cleaned up with C18 tip. The extracted peptides were dried
down. Proteomic samples were fractionated in a StageTip casted with four SDB-RPS disks (3 M Empore SPE
disks). Peptides were sequentially eluted with four buffers of increasing salt content. The four fractions were
dried under vacuum and dissolved with 0.1% formic acid for LC–MS analysis. Fractions of each sample were
analyzed by LC–MS with a Dionex RSLCnano HPLC coupled to an Orbitrap Fusion Lumos (Thermo Scientific)
mass spectrometer using a 2 h gradient. Peptides were resolved using 75 µm × 50 cm PepMap C18 column
(Thermo Scientific). Sequence mapping and label-free quantification were achieved using MaxQuant (version
1.6.1). MaxQuant was set up to search Human reference proteome (Uniprot.org). The digestion enzyme was set
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as trypsin. Carbamidomethylation of cysteine was set as fixed modification. Oxidation of methionine and acetylation of N-terminal of protein were specified as variable modifications.

Optic nerve regeneration assay.

All surgical procedures were performed under isofluorane anesthesia
according to approved guidelines by the Washington University in St. Louis School of Medicine Institutional
Animal Care and Use Committee. To generate AAV constructs, GFP or CREB (human sequence) were subcloned
into an AAV transfer plasmid provided by the Washington University Viral Core which uses the CMV promoter.
AAV2 viral particles were generated by Washington University Viral Core with titers for AAV2-CREB-VP64
(2.4 × 1012 vg/ml) and AAV2-GFP (1.7 × 1013 vg/ml). Five week old C57Bl/6 mice were anesthetized with isoflurane and intravitreally injected with 1.25 µl of the AAV2-CREB-VP64 or AAV2-GFP virus two weeks before
optic nerve crush using a Hamilton syringe and a pulled glass attached by an adaptor. Optic nerve crush was
performed by a surgeon blinded to treatment as previously d
 escribed23. Mice were anesthetized by isoflurane
inhalation, and optic nerve was exposed and crushed for 3 s with a 55 forceps. For analgesia, 1 mg/kg buprenorphine SR-LAB (ZooPharm) was administered subcutaneously. Two weeks after surgery, mice were intravitreally
injected with 1.5 µl of 1 mg/ml fluorescent Cholera toxin B. Two days after, animals were sacrificed by C
 O2
inhalation and perfused with PBS followed by 4% Paraformaldehyde. Nerves were dissected out and post-fixed
for 4 h, washed in PBS and incubated in 30% Sucrose solution overnight at 4 Celsius. Nerves were then dissected
and sectioned at 11 µm thickness. Optic nerve sections were imaged in a florescent microscope. The number of
axons growing at 250, 500, 750 and 1000 µm distal from the injury site were quantified by a researcher blinded
to treatment. Multiple t-test analysis with Holm-Sidak correction was performed.
For RGC survival assay, eyes were dissected out of the orbit with Vanna scissors and immersed in 4% PFA
overnight at 4 °C. Eyes were transferred to PBS and the cornea, iris, lens, sclera, choroid were removed and the
whole retina collected in a 24-well plate under a dissection microscope as d
 escribed77. Following five 5-min
washes with PBS, TBST blocking buffer (10% normal donkey serum, 0.5% TritonX-100 in PBS) was applied for
3 h at room temperature with gentle rotation. This was replaced with anti-RBPMS primary antibody (generous
gift by Dr. Philip Williams, Cat# ABN1376, EMD Millipore, USA; 1:500) or anti-GFP in TBST blocking buffer
at 4 °C overnight with gentle rotation. Following five further 5-min washes with PBS, retina were incubated
with Alexa Fluor 594 secondary antibody (1:300) in TBST blocking buffer at room temperature for 2.5 h with
gentle rotation. After five further washes with PBS, retina was flattened with four incision and mounted onto
charged Superfrost microslides using ProLong Gold antifade mounting reagent (Invitrogen) and allowed to dry
overnight at 4 °C. Images of flat mount retina (5 images/flat mount, 1–2 images/quadrant) were acquired using
epifluorescence microscope Nikon Eclipse Ti2 with a 40 × objective. Blinded manual counting of all images was
performed (100µm2 area in each count and 5 count/image). Uninjured eyes were counted (n = 3–4 per group)
and the averaged used to normalize the percentage RGC survival.
To count GFP positive RGC, three images of each flat mount retina were used to count GFP positive and
RBPMS positive cells and the % of GFP positive cells was calculated with respect to total RBPMS positive cells
in each image.

Data availability

The raw FASTQ files were deposited at the NCBI GEO database under the accession number GSE163564.
Received: 2 March 2021; Accepted: 5 July 2021
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